Clinical Trials in Phoenix

Showing 8281-8300 of 16,646 trials

OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

NCT03180307

This is a phase 3, randomized, multi-center, single dose, open label, pivotal study in patients diagnosed with, or with high clinical suspicion of, ovarian cancer scheduled to undergo primary surgical cytoreduction, interval debulking, or recurrent ovarian cancer surgery.

Ovarian Cancer

On Target Laboratories, LLC140 participantsStarted Jan 2018

Phoenix, Arizona, United States • Tucson, Arizona, United States • Duarte, California, United States +8 more locations

TERMINATEDPhase 2< 1 mile

Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis

NCT03059446

This rollover study will provide open-label treatment with cenicriviroc and will assess the long-term safety of continued treatment with cenicriviroc in participants who participated in either the CENTAUR study 652-2-203 \[NCT02217475\] or the AURORA study \[NCT03028740\].

Nonalcoholic SteatohepatitisLiver CirrhosisNon-alcoholic Fatty Liver Disease

Tobira Therapeutics, Inc.167 participantsStarted Feb 2017

Dothan, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +68 more locations

OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis

Find Trials by Condition in Phoenix

Benefits of Exercise Program in Pediatric HSCT

Clinical Evaluation of a Daily Wear Silicone Hydrogel Lens

Tolperisone in Acute Muscle Spasm of the Back

Multi-limb Dual-task Control in Parkinson's Disease

Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma

STARS-R Registry: Retrospective Analysis of Poly-4-hydroxybutyrate (P4HB) Scaffold Use

Feasibility of Telemedicine Medical Abortion

SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes

Driving Simulation to Assess Non-Sedative Effects of Tolperisone

Safety Study of Enoblituzumab (MGA271) in Combination With Ipilimumab in Refractory Cancer

Improving Critical Congenital Heart Disease Screening With Addition of Perfusion Measurements

Study of TBX-3400 in Subjects With Solid Malignant Tumors Resistant or Refractory to Standard Therapies

Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.

Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

Phase 1 Study of MGD007 in Relapsed/Refractory Metastatic Colorectal Carcinoma

MGD007 Combined With MGA012 in Relapsed/Refractory Metastatic Colorectal Cancer